SECURITIES AND EXCHANGE COMMISSION
                   Washington, D.C. 20549
                          FORM 8-K
                       CURRENT REPORT
               PURSUANT TO SECTION 13 OR 15(d)
           OF THE SECURITIES EXCHANGE ACT OF 1934
              Date of Report: October 23, 2003
                  CALLOWAY'S NURSERY, INC.
   (Exact name of registrant as specified in its charter)
                            Texas
(State or other jurisdiction of incorporation or organization)
                           0-19305
                  (Commission File Number)
                         75-2092519
            (IRS Employer Identification Number)
               4200 Airport Freeway, Suite 200
                Fort Worth, Texas 76106-1911
(Address of principal executive offices, including zip code)
                        817.222.1122
    (Registrant's telephone number, including area code)


Item 5.     OTHER EVENTS

On October 24, 2002 the Company received a letter from
NASDAQ indicating that the Company's common stock had closed
below the minimum $1.00 per share requirement for continued
inclusion under Marketplace Rule 4310(c)(4), and that the
Company would be provided 180 calendar days, or until April
22, 2003, to demonstrate compliance. Furthermore, on April
23, 2003 the Company received a letter from NASDAQ
indicating that the Company met the initial listing
requirements for the NASDAQ SmallCap Market under
Marketplace Rule 4310(c)(2)(A). Since the Company met the
initial listing requirements, the Company was granted an
additional 180 calendar day grace period, or until October
20, 2003, to demonstrate compliance.

On October 22, 2003 the Company received a letter from
NASDAQ indicating that the Company had not regained
compliance in accordance with Marketplace Rule
4310(c)(8)(D). However, since the Company met the initial
listing requirements for the NASDAQ SmallCap Market under
Marketplace Rule 4310(c)(2)(A), the Company was granted an
additional 90 calendar day grace period, or until January 2,
2004, to demonstrate compliance.
If compliance with the aforementioned rule cannot be
demonstrated by January 21, 2004, NASDAQ will provide
written notification that the Company's common stock will be
delisted. At that time, the Company may appeal such
determination to a Listing Qualifications Panel.

                              CALLOWAY'S NURSERY, INC.

                              By:/s/ Daniel G. Reynolds
                              Daniel G. Reynolds
                              Vice President and Chief
                              Financial Officer
[{"type": "8-K", "sequence": "1", "filename": "clwy.txt", "description": "ITEM 5", "secsgml_size_bytes": 2604}]
{"company-data": {"conformed-name": "CALLOWAYS NURSERY INC", "cik": "0000874759", "assigned-sic": "5200", "irs-number": "752092519", "state-of-incorporation": "TX", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-19305", "film-number": "03953271"}, "business-address": {"street1": "4200 AIRPORT FREEWAY", "city": "FORT WORTH", "state": "TX", "zip": "76117-6200", "phone": "8176248222"}, "mail-address": {"street1": "4800 BLUE MOUND ROAD", "city": "FORT WORTH", "state": "TX", "zip": "76106-1911"}}
SECURITIES AND EXCHANGE COMMISSION
                   Washington, D.C. 20549
                          FORM 8-K
                       CURRENT REPORT
               PURSUANT TO SECTION 13 OR 15(d)
           OF THE SECURITIES EXCHANGE ACT OF 1934
              Date of Report: October 23, 2003
                  CALLOWAY'S NURSERY, INC.
   (Exact name of registrant as specified in its charter)
                            Texas
(State or other jurisdiction of incorporation or organization)
                           0-19305
                  (Commission File Number)
                         75-2092519
            (IRS Employer Identification Number)
               4200 Airport Freeway, Suite 200
                Fort Worth, Texas 76106-1911
(Address of principal executive offices, including zip code)
                        817.222.1122
    (Registrant's telephone number, including area code)

Item 5.     OTHER EVENTS

On October 24, 2002 the Company received a letter from
NASDAQ indicating that the Company's common stock had closed
below the minimum $1.00 per share requirement for continued
inclusion under Marketplace Rule 4310(c)(4), and that the
Company would be provided 180 calendar days, or until April
22, 2003, to demonstrate compliance. Furthermore, on April
23, 2003 the Company received a letter from NASDAQ
indicating that the Company met the initial listing
requirements for the NASDAQ SmallCap Market under
Marketplace Rule 4310(c)(2)(A). Since the Company met the
initial listing requirements, the Company was granted an
additional 180 calendar day grace period, or until October
20, 2003, to demonstrate compliance.

On October 22, 2003 the Company received a letter from
NASDAQ indicating that the Company had not regained
compliance in accordance with Marketplace Rule
4310(c)(8)(D). However, since the Company met the initial
listing requirements for the NASDAQ SmallCap Market under
Marketplace Rule 4310(c)(2)(A), the Company was granted an
additional 90 calendar day grace period, or until January 2,
2004, to demonstrate compliance.
If compliance with the aforementioned rule cannot be
demonstrated by January 21, 2004, NASDAQ will provide
written notification that the Company's common stock will be
delisted. At that time, the Company may appeal such
determination to a Listing Qualifications Panel.

                              CALLOWAY'S NURSERY, INC.

                              By:/s/ Daniel G. Reynolds
                              Daniel G. Reynolds
                              Vice President and Chief
                              Financial Officer